https://www.selleckchem.com/pr....oducts/aminoguanidin
039) were significantly higher in HP than in CAD. No significant difference appeared in Sfv (CAD -0.27 ± 0.07 N.kg-1.m.s-1 vs. HS -0.28 ± 0.07 N.kg-1.m.s-1, p = 0.541). Conclusion The lower maximal power in CAD patients was related to both a lower V 0 and F 0. Physical inactivity, sedentary time and high cardiovascular disease (CVD) risk may explain this difference of force production at both high and low velocities between the two groups. Copyright © 2020 Fanget, Rossi, Samozino, Morin, Testa, Roche, Busso, Laukkan
Like
Comment
Share
